Summit Therapeutics
SMMT
#2227
Rank
$8.39 B
Marketcap
$10.50
Share price
-1.59%
Change (1 day)
-38.05%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): -$1.07

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.07. In 2025 the company made an earnings per share (EPS) of -$1.45.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$1.07-26.21%
2025-$1.45
2021-$0.9626.32%
2020-$0.76
2018-$0.04340-84.63%
2017-$0.28-40.59%
2016-$0.486.54%
2015-$0.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-$2.63 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
$13.86-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-$1.03-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA